Angela studied Biomedical Engineering, obtaining a Ph.D. in Systems Biology allowing her to operate at the intersection of biology and medicine as viewed through the lens of data science. During her Ph.D., Angela investigated how drug resistance emerges during chemotherapy and discovered that cancer cells can adapt to the presence of a drug by acquiring a reversible resistant behavior in response to the treatment. Before joining the CZ Biohub, Angela was a postdoctoral fellow at King’s College London, where she explored the mechanisms of cellular differentiation in the skin. Angela leads the Quantitative Cell Science arm of CZ Biohub’s Data Science team, building tools and datasets that advance understanding of health and disease.
BACK TO ALL